The perspective of combining pulsed field ablation and left atrial appendage closure
Europace · 2026
DOI: 10.1093/europace/euag202 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Europace, 2026. Verfasst von Lucas Boersma und 10 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Department, St. Antonius Hospital Nieuwegein/Amsterdam University Medical Centre, Nieuwegein, the Netherlands. Hauptthemen laut MEDLINE: Left Atrial Appendage Closure, Atrial Fibrillation, Thromboembolism, Atrial Appendage. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Boston Scientific.
Abstract (Originalsprache)
Pulsed field ablation (PFA) and left atrial appendage closure (LAAC) are increasingly discussed as complementary strategies in atrial fibrillation (AF) care, addressing rhythm control and long-term thromboembolic risk. The rationale is attractive, but the current evidence base is uneven. Randomized evidence for LAAC around AF ablation is strongest for thermal-ablation-era workflows, particularly the OPTION trial, which showed lower non-procedure-related major or clinically relevant non-major bleeding with LAAC than with oral anticoagulation (OAC) and non-inferiority for death, stroke, or systemic embolism. Dedicated PFA-specific evidence remains limited to feasibility studies and early observational experience, and no trial has demonstrated that combined ablation-LAAC procedures are clinically superior when the ablation component is performed with PFA rather than radiofrequency or cryoballoon ablation. In parallel, OAC-withdrawal trials after apparently successful ablation, including OCEAN and ALONE-AF, have reported low thromboembolic event rates in selected lower-risk populations, whereas CLOSURE-AF cautions against simple extrapolation of LAAC benefit to older, frailer patients at high stroke and bleeding risk. This review therefore positions combined PFA-LAAC as a potential option for carefully selected patients rather than an established routine strategy. We summarize procedural workflow, patient selection, trial populations, device-platform considerations, reimbursement and organizational issues, and the main uncertainties that should guide future prospective studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Cardiology Department, St. Antonius Hospital Nieuwegein/Amsterdam University Medical Centre, Nieuwegein, the Netherlands.
- Cardiovascular Research Centre Aalst, AZORG Aalst, Aalst, Belgium.
- Department of Rhythmology, Asklepios Clinic Altona, Hamburg, Germany.
- Department of Rhythmology, University of Lübeck, Lubeck, Germany.
- Department of Cardiac Electrophysiology and Research, St. Bernard's Heart and Vascular Center, Arrhythmia Research Group, Jonesboro, AR, USA.
- Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Switzerland.
ORCID-Profile: Lucas Boersma, Tom De Potter, Christian-Hendrik Heeger, Devi Nair, Laurent Roten, Marco Schiavone, Claudio Tondo, Pierpaolo Iozzia, Mounia Haddad, Kars Neven
Förderung
- Boston Scientific
Zitieren
APA
Boersma, L., De Potter, T., Heeger, C. H., Nair, D., Roten, L., Schiavone, M., Tondo, C., Iozzia, P., Giabbani, I., Haddad, M., & Neven, K. (2026). The perspective of combining pulsed field ablation and left atrial appendage closure. Europace. https://doi.org/10.1093/europace/euag202
Vancouver
Boersma L, De Potter T, Heeger CH, Nair D, Roten L, Schiavone M, et al. The perspective of combining pulsed field ablation and left atrial appendage closure. Europace. 2026. doi:10.1093/europace/euag202
BibTeX
@article{Boersma2026,
author = {Boersma, Lucas and De Potter, Tom and Heeger, Christian-Hendrik and Nair, Devi and Roten, Laurent and Schiavone, Marco and Tondo, Claudio and Iozzia, Pierpaolo and Giabbani, Ilaria and Haddad, Mounia and Neven, Kars},
title = {The perspective of combining pulsed field ablation and left atrial appendage closure},
journal = {Europace},
year = {2026},
doi = {10.1093/europace/euag202}
}
EUVIMED